Doctors Test the Limits of What Obesity Drugs Can Fixnews2024-06-18T09:13:35+00:00June 18th, 2024|The New York Times|
What to Know About Ozempic and Other Drugs Used for Weight Lossnews2024-05-20T09:01:24+00:00May 20th, 2024|The New York Times|
Ozempic Is Repairing a Hole in Our Diets Created by Processed Foodsnews2024-05-07T11:01:48+00:00May 7th, 2024|The New York Times|
Inside Novo Nordisk, the Company Behind Ozempic and Wegovynews2024-04-20T04:01:23+00:00April 20th, 2024|The New York Times|
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reportsnews2024-04-17T18:33:32+00:00April 17th, 2024|The New York Times|
Por qué la gente odia las medicinas de por vida y por qué Ozempic sería distintonews2024-03-26T04:02:05+00:00March 26th, 2024|The New York Times|
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?news2024-03-24T19:21:34+00:00March 24th, 2024|The New York Times|
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Studynews2024-02-05T16:10:45+00:00February 5th, 2024|The New York Times|
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptionsnews2024-02-02T20:20:57+00:00February 2nd, 2024|The New York Times|
